178 related articles for article (PubMed ID: 19521960)
1. Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome.
Shnaper S; Desbaillets I; Brown DA; Murat A; Migliavacca E; Schluep M; Ostermann S; Hamou MF; Stupp R; Breit SN; de Tribolet N; Hegi ME
Int J Cancer; 2009 Dec; 125(11):2624-30. PubMed ID: 19521960
[TBL] [Abstract][Full Text] [Related]
2. Human chorionic gonadotropin detection in cerebrospinal fluid of patients with a germinoma and its prognostic significance: assessment by using a highly sensitive enzyme immunoassay.
Fukuoka K; Yanagisawa T; Suzuki T; Shirahata M; Adachi JI; Mishima K; Fujimaki T; Katakami H; Matsutani M; Nishikawa R
J Neurosurg Pediatr; 2016 Nov; 18(5):573-577. PubMed ID: 27391806
[TBL] [Abstract][Full Text] [Related]
3. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
4. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease.
Breit SN; Carrero JJ; Tsai VW; Yagoutifam N; Luo W; Kuffner T; Bauskin AR; Wu L; Jiang L; Barany P; Heimburger O; Murikami MA; Apple FS; Marquis CP; Macia L; Lin S; Sainsbury A; Herzog H; Law M; Stenvinkel P; Brown DA
Nephrol Dial Transplant; 2012 Jan; 27(1):70-5. PubMed ID: 21940482
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
Schmid D; Warnken U; Latzer P; Hoffmann DC; Roth J; Kutschmann S; Jaschonek H; Rübmann P; Foltyn M; Vollmuth P; Winkler F; Seliger C; Felix M; Sahm F; Haas J; Reuss D; Bendszus M; Wildemann B; von Deimling A; Wick W; Kessler T
J Neurochem; 2021 Jul; 158(2):522-538. PubMed ID: 33735443
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophage related interleukin-6 in cerebrospinal fluid as a prognostic marker for glioblastoma.
Hori T; Sasayama T; Tanaka K; Koma YI; Nishihara M; Tanaka H; Nakamizo S; Nagashima H; Maeyama M; Fujita Y; Yokozaki H; Hirose T; Kohmura E
J Clin Neurosci; 2019 Oct; 68():281-289. PubMed ID: 31327593
[TBL] [Abstract][Full Text] [Related]
7. The regulation of cysteine cathepsins and cystatins in human gliomas.
Gole B; Huszthy PC; Popović M; Jeruc J; Ardebili YS; Bjerkvig R; Lah TT
Int J Cancer; 2012 Oct; 131(8):1779-89. PubMed ID: 22287159
[TBL] [Abstract][Full Text] [Related]
8. Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study.
Fuchs T; Trollor JN; Crawford J; Brown DA; Baune BT; Samaras K; Campbell L; Breit SN; Brodaty H; Sachdev P; Smith E
Aging Cell; 2013 Oct; 12(5):882-9. PubMed ID: 23758647
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma multiforme with epithelial differentiation: a potential diagnostic pitfall in cerebrospinal fluid cytology.
Gill SK; Padmanabhan V; Hickey WF; Marotti JD
Diagn Cytopathol; 2015 Aug; 43(8):638-41. PubMed ID: 25913842
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
[TBL] [Abstract][Full Text] [Related]
11. The TGF-beta superfamily cytokine MIC-1/GDF15: secretory mechanisms facilitate creation of latent stromal stores.
Bauskin AR; Jiang L; Luo XW; Wu L; Brown DA; Breit SN
J Interferon Cytokine Res; 2010 Jun; 30(6):389-97. PubMed ID: 20187768
[TBL] [Abstract][Full Text] [Related]
12. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
13. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality.
Wiklund FE; Bennet AM; Magnusson PK; Eriksson UK; Lindmark F; Wu L; Yaghoutyfam N; Marquis CP; Stattin P; Pedersen NL; Adami HO; Grönberg H; Breit SN; Brown DA
Aging Cell; 2010 Dec; 9(6):1057-64. PubMed ID: 20854422
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
[TBL] [Abstract][Full Text] [Related]
15. The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism.
Breit SN; Johnen H; Cook AD; Tsai VW; Mohammad MG; Kuffner T; Zhang HP; Marquis CP; Jiang L; Lockwood G; Lee-Ng M; Husaini Y; Wu L; Hamilton JA; Brown DA
Growth Factors; 2011 Oct; 29(5):187-95. PubMed ID: 21831009
[TBL] [Abstract][Full Text] [Related]
16. Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI.
Tsai VW; Macia L; Feinle-Bisset C; Manandhar R; Astrup A; Raben A; Lorenzen JK; Schmidt PT; Wiklund F; Pedersen NL; Campbell L; Kriketos A; Xu A; Pengcheng Z; Jia W; Curmi PM; Angstmann CN; Lee-Ng KK; Zhang HP; Marquis CP; Husaini Y; Beglinger C; Lin S; Herzog H; Brown DA; Sainsbury A; Breit SN
PLoS One; 2015; 10(7):e0133362. PubMed ID: 26207898
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients.
Shi W; Lv C; Qi J; Zhao W; Wu X; Jing R; Wu X; Ju S; Chen J
J Mol Neurosci; 2012 Mar; 46(3):470-5. PubMed ID: 21881830
[TBL] [Abstract][Full Text] [Related]
18. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.
Teplyuk NM; Mollenhauer B; Gabriely G; Giese A; Kim E; Smolsky M; Kim RY; Saria MG; Pastorino S; Kesari S; Krichevsky AM
Neuro Oncol; 2012 Jun; 14(6):689-700. PubMed ID: 22492962
[TBL] [Abstract][Full Text] [Related]
20. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
